Moderna Inc.

莫德纳公司

MRNA

信使核糖核酸

on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE (COVID-19 Vaccine, mRNA), which targets the LP.8.1

周二发布了mNEXSPIKE（新冠疫苗，mRNA）2025-2026配方的初步免疫原性数据，该疫苗针对LP.8.1。

variant of SARS-CoV-2

SARS-CoV-2变异株

.

。

The data from an ongoing Phase 4 clinical trial evaluating the safety, tolerability, and immunogenicity of the 2025-2026 formula of mNEXSPIKE showed, on average, greater than a 16-fold increase in neutralizing antibodies against the LP.8.1 variant in individuals 12 through 64 years of age with at least one underlying condition and all adults .

一项正在进行的第四阶段临床试验的数据评估了2025-2026年配方的mNEXSPIKE的安全性、耐受性和免疫原性，数据显示，在12至64岁至少有一种基础疾病的人群以及所有成年人中，针对LP.8.1变体的中和抗体平均增加了16倍以上。

65 years of age and older

65岁及以上

.

。

These findings follow additional preliminary data that showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies

这些发现基于额外的初步数据，数据显示2025-2026年的Spikevax配方产生了超过8倍的LP.8.1中和抗体增长。

across the same age groups

跨越相同的年龄组

.

。

Also Read:

另请阅读：

Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: ‘This Is Based On What I Feel’

特朗普建议父母分开接种疫苗，推迟到12岁再注射乙肝疫苗：“这是基于我的感觉”

The safety profile of the vaccine was consistent with previous studies. These clinical findings underscore the predictability of preclinical data that supported the recent U.S. Food and Drug Administration approval of the 2025-2026 formula of mNEXSPIKE.

疫苗的安全性特征与之前的研究一致。这些临床结果强调了支持美国食品药品监督管理局近期批准2025-2026年mNEXSPIKE配方的临床前数据的可预测性。

Politics Around Vaccines

疫苗政治

Earlier in September, shares of COVID-19 vaccine makers, including Moderna, fell following a Washington Post report that Trump administration health officials intend to link the vaccines to 25 child deaths.

九月上旬，《华盛顿邮报》报道称，特朗普政府的卫生官员打算将疫苗与25名儿童的死亡联系起来，随后包括Moderna在内的新冠疫苗制造商的股票下跌。

The assertion is reportedly based on unverified submissions to the Vaccine

该主张据报道是基于未经核实的疫苗提交材料

Adverse Event Reporting System

不良事件报告系统

. The plan alarmed career scientists, who note the vaccines have been extensively studied.

该计划令职业科学家感到震惊，他们指出疫苗已经过广泛研究。

According to the report, Trump officials will present the claim to an influential CDC advisory panel next week.

根据报告，特朗普政府官员将在下周向一个有影响力的疾控中心顾问小组提出这一主张。

Top health officials under the U.S. Health and Human Services Secretary

美国卫生与公众服务部长麾下的高级卫生官员

Robert F. Kennedy Jr.

罗伯特·F·肯尼迪 Jr.

are intensifying efforts to gather and publicize data on potential harms caused by COVID-19 vaccines, particularly

正在加大力度收集和宣传有关新冠疫苗可能造成的危害的数据，尤其是

in pregnant women

孕妇

.

。

MRNA Price Action:

MRNA价格走势：

Moderna shares were down 0.40% at $26.45 at the time of publication on Tuesday. The stock is trading near its 52-week low of $23.15

Moderna股价在周二发布时下跌0.40%，至26.45美元。该股交易接近其52周低点23.15美元。

, according to Benzinga Pro data

，根据Benzinga Pro数据

.

。

Loading...

加载中...

Loading...

加载中...

Read Next:

接下来阅读：

Trump Family’s World Liberty Financial Platform Gears Up To Introduce Debit Card, Retail App: Report

特朗普家族的环球自由金融平台准备推出借记卡和零售应用：报告称

Photo by Niamul Rifat via Shutterstock

照片由Niamul Rifat通过Shutterstock提供

MRNA

信使核糖核酸

Moderna Inc

莫德纳公司

$26.45

26.45美元

-0.41

-0.41

%

%

Overview

概述

Market News and Data brought to you by Benzinga APIs

由Benzinga API提供的市场新闻和数据

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

© 2025 Benzinga.com. Benzinga不提供投资建议。保留所有权利。